At Pharmidex, we provide integrated bioanalytical solutions designed to support every stage of your drug development journey.

Our comprehensive bioanalysis services generate high-quality, regulatory-ready data to enable confident decision-making, from early discovery through to clinical development.

Our capabilities span biomarker analysis, discovery bioanalysis, drug metabolism and In Vitro ADMET, alongside specialised platforms including flow cytometry and haematology. We also offer expertise in physicochemical property assessment and regulatory bioanalysis, ensuring a seamless transition from exploratory studies to compliant, submission-ready data packages.

With a strong focus on method development, validation and regulatory compliance, our expert teams apply advanced analytical techniques to deliver precise quantitative insights across a wide range of modalities, from small molecules to complex biologics.

By integrating scientific expertise with flexible delivery, we help streamline workflows, reduce risk, and accelerate development timelines. Partner with Pharmidex bioanalysis services to gain the clarity and confidence needed to progress your programmes and unlock the full potential of your therapeutic innovations.